Skip to Main Content
  • Nederlands
  • English
  • Français
  • Linde wereldwijd
  • The Linde Group
  • Over Linde
  • Woordenlijst
  • Healthcare
    België

  • Welkom bij Linde Healthcare
  • Over Linde Healthcare
      • Missie
      • Medische professionals
      • Patiëntgerichte zorg
      • Innovatie
        • Innovatie in gezondheidszorg
        • Uw partner
        • REALfund
      • Onze kerncijfers
      • Locaties
      • Vacatures
  • Therapieën
      • NO-therapie
        • Wat kan Linde hierin voor u betekenen?
        • Veelgestelde vragen NO therapie
      • Pijnbestrijding
        • Wat kan Linde hierin voor u betekenen?
          • RELIVOPAN®
          • Zuurstoftherapie
            • Palliatieve therapie
            • Clusterhoofdpijn
        • Veelgestelde vragen over pijnbestrijding
      • Slaapapneu therapie
        • Wat kan Linde hierin voor u betekenen?
        • Veelgestelde vragen over slaapapneu therapie
      • Voedingstherapie
        • Wat kan Linde hierin voor u betekenen?
        • Veelgestelde vragen over voedingstherapie
      • Zuurstoftherapie
        • Wat kan Linde hierin voor u betekenen?
        • Veelgestelde vragen over zuurstoftherapie
  • Producten & services
      • Per categorie
        • Medische en medicinale gassen
          • Kalibratiegassen
          • CONOXIA® medicinale zuurstof
          • INOmax® - NO mengsel (stikstofmonoxide voor inhalatie)
          • Medische kooldioxide
          • Cardiopulmonale testgassen
          • Medische stikstof
          • AIRAPY® medicinale lucht
          • NIONTIX® medicinaal lachgas
          • RELIVOPAN® medicinaal lachgas/zuurstofmengsel
          • Medische speciale & laboratoriumgassen
        • Apparatuur in de thuisomgeving
          • APAP apparatuur
          • Bi-level apparatuur
          • CPAP apparatuur
          • Systemen met vloeibare zuurstof
          • Voedingspompen
          • Zuigapparatuur
          • Zuurstofcilinders
            • Met geïntegreerde drukregelaar
          • Zuurstofconcentratoren
        • Apparatuur in de ziekenhuisomgeving
          • LIV® Linde Integrated Valve
          • Cilinderopbergsystemen
          • Cilinders
            • Cilinders met geïntegreerde drukregelaar (LIV®)
          • Concentratoren
          • Cryogene opbergsystemen
          • Cryogene opslag en distributie van vloeibare stikstof
            • Open dewars
            • Junior vaten
            • Transportvaten
            • Drukloze vaten
            • Drukvaten
            • Accessoires
          • Dry-shipper transport
          • Biologische bewaarvaten
            • Kleine biologische bewaarvaten
            • Middelgrote biologische bewaarvaten
            • Biologische bulkopslag
            • Accessoires
          • CryoPro®
          • Gasdetectie
            • Stationaire gasdetectie
            • Verstikkingsgevaar
            • Veiligheidscursus omgaan met vloeibare stikstof
          • Invriesapparatuur
            • IceCube 14 Series
            • CL systeem
            • CVM vitrificatie
          • Leidingsystemen
          • Monitoring & Besturing
          • Persoonlijke Beschermingsmiddelen
          • Veiligheid
          • Reduceerventielen
          • Sample beheer
          • Systemen met vloeibare zuurstof
            • Ambulox
            • Helios
          • Toedieningssysteem NO INOmax® DSIR
        • Cryoservices
        • Cryogene gassen
          • Vloeibare kooldioxide
          • Vloeibare stikstof
        • Enterale voeding
          • Sondevoeding
        • Services
          • LIV®LINE
          • QI Services
            • Analyse
            • Audit kwaliteitsysteem
            • Biobank
            • Centraal leidingnetwerk & tanks
            • Cilinder tracking & tracing
            • Quickscan
            • Training
          • Sample Beheer
          • Stikstofleveringen
            • CryoCare
            • CryoKoerier
            • CryoLIN
            • Cryomove
            • Lab2Lab
            • LabSealBags
          • Training
          • Veiligheidstraining
      • Per medisch specialisme
        • Anesthesie
          • AIRAPY® medicinale lucht
          • CONOXIA® medicinale zuurstof
          • NIONTIX® medicinaal lachgas
          • RELIVOPAN® medicinaal lachgas/zuurstofmengsel
        • KNO
          • Slaapapneu therapie
        • Intensive care
          • Medische helium/zuurstofmengsels
          • CONOXIA® medicinale zuurstof
        • Neonatologie
          • INOmax®, NO mengsel (stikstofmonoxide voor inhalatie)
        • Neurologie
          • Medicinale zuurstof
        • Obstetrie
          • RELIVOPAN® (medicinaal lachgas/zuurstofmengsels)
        • Ondervoeding
          • Sondevoeding
        • Pijnbestrijding
          • Clusterhoofdpijn
          • RELIVOPAN® (medicinaal lachgas/zuurstofmengsels)
        • Pulmonologie
          • Medicinale cardiopulmonale testgassen
          • CONOXIA® medicinale zuurstof
          • Slaapapneu therapie
      • Per zorggebied
        • Spoedeisende hulp
          • LIV® Linde Integrated Valve
          • LIV®LINE
          • RELIVOPAN® (medicinaal lachgas/zuurstofmengsels)
          • CONOXIA® medicinale zuurstof
          • Voorzieningen en toebehoren
        • Thuiszorg
          • Clusterhoofdpijn
          • LIV® (Linde Integrated Valve)
          • Zuurstoftherapie
          • Beademingstherapie
          • Voeding
          • Slaapapneutherapie
        • Institutionele zorg
          • INOmax®, NO mengsel (stikstofmonoxide voor inhalatie)
          • LIV® Linde Integrated Valve
          • AIRAPY® medicinale lucht
          • NIONTIX® medicinaal lachgas
          • RELIVOPAN® (medicinaal lachgas/zuurstofmengsels)
          • CONOXIA® medicinale zuurstof
  • Contact
      • E-mail ons
  • News & media
      • Persberichten
      • Evenementen
        • Evenementen archief
      • Publicaties
      • Beeldbank
      • Videoportaal
      • Brochures & downloads
        • Algemene Voorwaarden
        • Brochures
        • Certificaten
        • Gebruiksaanwijzingen
        • Zuurstof toedieningssystemen
      • Linde @ Social Media
  •  
  • Language
    • Nederlands
    • English
    • Français
  • Linde wereldwijd
  • The Linde Group
  • Over Linde
  • Werken bij Linde
  • Woordenlijst
  • News & media
  • Persberichten
  • Evenementen
  • Publicaties
  • Beeldbank
  • Videoportaal
  • Brochures & downloads
  • Linde @ Social Media
  • News & media
  • Persberichten
  • 2015-10-15 Linde develops a new production process for synthesis gas

Linde develops a new production process for synthesis gas

Corporate News

  • EUR 5 million investment to expand research and development facilities at Pullach near Munich – Linde’s largest location worldwide
  • Innovative dry reforming process developed in cooperation with Linde partners
  • New process enables energy-efficient, low-emission synthesis gas production with economical industrial-scale use of CO2 as feedstock
  • Dr Büchele commented: “The official opening of the pilot reformer is further proof of our customer-centric approach to development.”

Picture of the Linde Pilot Reformer (LPR) in Pullach, Germany.

LPR:  As part of the R&D strategy, Linde has invested into and constructed a pilot facility to test the dry-reforming technology. Linde is using the facility to run tests in the area of reforming technology. The insights and learning will be used to develop and establish new reforming processes as well as for testing new concepts. 
Linde Dry Reforming Technology has been developed by Linde. 
Reforming process allowing carbon dioxide recycle/import for hydrogen/syngas production. It is a combination of process know-how, engineering, plant construction. The process is currently being tested in the Linde Pilot Reformer facility at Linde HQ in Pullach.

Munich, 15 October 2015 - Today, technology company The Linde Group officially opened the new Linde Pilot Reformer research facility at Pullach near Munich – Linde’s largest location worldwide. The event was attended by customers, partners and employees.

Linde has invested approximately EUR 5 million in total to expand Pullach’s research and development capacity. The Linde Pilot Reformer will be used to refine steam reforming technology for the production of synthesis gas – a mixture consisting of hydrogen (H2) and carbon monoxide (CO). The carbon feedstock for synthesis gas can be in the form of natural gas, liquid petroleum gas (LPG), naphtha or even carbon dioxide (CO2). 

“Inventiveness and innovation are ingrained in Linde’s DNA. The official opening of the pilot reformer provides further proof of our customer-centric approach to development and sends a strong signal confirming Germany’s role as an innovation hub,” commented Dr Wolfgang Büchele, Chief Executive Officer of Linde AG.

“Linde intends to use this pilot facility to test and optimise all kinds of approaches to reforming. The insights we gain will help us further improve reforming processes and concepts for our customers,” adds Dr Christian Bruch, Member of the Executive Board of Linde AG and responsible for Technology and Innovation as well as the Engineering Division.

Picture of the Linde Pilot Reformer (LPR) in Pullach, Germany.

LPR:  As part of the R&D strategy, Linde has invested into and constructed a pilot facility to test the dry-reforming technology. Linde is using the facility to run tests in the area of reforming technology. The insights and learning will be used to develop and establish new reforming processes as well as for testing new concepts. 
Linde Dry Reforming Technology has been developed by Linde. 
Reforming process allowing carbon dioxide recycle/import for hydrogen/syngas production. It is a combination of process know-how, engineering, plant construction. The process is currently being tested in the Linde Pilot Reformer facility at Linde HQ in Pullach.

Picture of the Linde Pilot Reformer (LPR) in Pullach, Germany.

LPR:  As part of the R&D strategy, Linde has invested into and constructed a pilot facility to test the dry-reforming technology. Linde is using the facility to run tests in the area of reforming technology. The insights and learning will be used to develop and establish new reforming processes as well as for testing new concepts. 
Linde Dry Reforming Technology has been developed by Linde. 
Reforming process allowing carbon dioxide recycle/import for hydrogen/syngas production. It is a combination of process know-how, engineering, plant construction. The process is currently being tested in the Linde Pilot Reformer facility at Linde HQ in Pullach.

Tests in the pilot reformer are currently focused on the dry reforming. This innovative process was developed by Linde in cooperation with its partners BASF and hte (responsible for catalyst development), Karlsruhe Institute of Technology / KIT (responsible for simulations) and DECHEMA (supplier of materials). The pilot project has been awarded funding by the German Ministry for Economic Affairs and Energy (BMWi) of just under one EUR million1.

The production of synthesis gas (a mixture of H2 and CO) through dry reforming of natural gas means that carbon dioxide (CO2) can be used on an industrial scale as an economical feedstock. The process is also significantly more energy efficient than the conventional method of reforming. The synthesis gas can be used to produce valuable downstream products such as base chemicals or fuels.
One such example is dimethyl ether (DME). The DME produced through dry reforming offers an improved energy balance and lower CO2 emissions.

The dry reforming process also offers cost efficiencies relative to partial oxidation – the conventional method used up to now to produce CO-rich synthesis gases. These would be of particular interest to small and medium-sized plants. 

If the dry reforming pilot proves successful, there are plans to commercialise the process when the funded project comes to an end in 2017 and build a reference plant for a Linde customer. 


1Funded by the Federal Republic of Germany, awarding authority: Federal Ministry for Economic Affairs and Energy based on a decision by the German Parliament, funding No. 03ET1282.


About The Linde Group

In the 2014 financial year, The Linde Group generated revenue of EUR 17.047 bn, making it the largest gases and engineering company in the world with approximately 65,500 employees working in more than 100 countries worldwide. The strategy of The Linde Group is geared towards long-term, profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.

For more information about The Linde Group, go to www.linde.com

 

Downloads
Linde develops a new production process for synthesis gas (PDF 61 KB) Linde Pilot Reformer - Pullach (Image 556 KB) Linde Pilot Reformer - Pullach (Image 312 KB) Linde Pilot Reformer - Pullach (Image 302 KB) The Linde Group Logo small (Image 37 KB) The Linde Group Logo medium (Image 75 KB) The Linde Group Logo large (Image 159 KB)
Contacts
  • Our Contacts for this Press Release

  • Media Relations

    Dr Thomas Hagn
    Phone +49.89.35757-1323

    Matthias Dachwald
    Phone +49.89.35757-1333

  • Investor Relations

    Dr Dominik Heger
    Phone +49.89.35757-1334

    Bernard Wang
    Phone +49.89.35757-1328

Copyright

Please name The Linde Group as the source and send us a copy of your publication. All images are available in JPG format.

More Information
  • Hydrogen and synthesis gas plants
  • Linde Pilot Reformer
    • LinkedIn Social Media icon
    • Twitter Social Media icon
    • YouTube Social Media icon
    • Facebook Social Media icon
    • Google Plus Social Media icon
    • Sitemap
    • Terms of Use
    • Legal Notice
    • Data Protection
    • General Terms and Conditions
  • © The Linde Group 2018

Om uw gebruikerservaring op onze websites te verbeteren, maken wij gebruik van cookies. Door gebruik te maken van deze website, gaat u automatisch akkoord met ons gebruik van cookies.
Op de pagina gegevensbescherming kunt u meer lezen over het gebruik van cookies.

You must check the "I accept cookies from Linde websites" box to accept.
Meer informatie